Prevalence of cervical high-risk human papillomavirus infections in kidney graft recipients

Annals of Transplantation

Volumn 18, Issue 1, 2013, Pages 656-660

  Mazanowska, Natalia ^a   Pietrzak, Bronisława ^a   Kamiński, Paweł ^a   Ekiel, Alicja ^b   Martirosian, Gayane ^a,b   Jabiry Zieniewicz, Zoulikha ^a   Wielgoś, Mirosław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cervical intraepithelial neoplasia (CIN); Human papillomavirus (HPV); Immunosuppressive therapy; Kidney transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; GLUCOCORTICOID; MYCOPHENOLIC ACID;

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MYCOPLASMA; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PROSPECTIVE STUDY; SEXUALITY; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 84890865396     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.884029     Document Type: Article

References (26)

1. Wong G, Chapman JR, Craig JC: Cancer screening in renal transplant recipients: what is the evidence?. Clin J Am Soc Nephrol, 2008; 3(Suppl. 2), S87-S100.
2. Vajdic CM, McDonald SP, McCredie MR et al: Cancer incidence before and after kidney transplantation. JAMA, 2006; 296(23): 2823-31.
3. Salimović-Besić I, Bokal EV, Poljak M, Kocjan B: Prevalence of human papillomavirus infection in Slovenian women with repeated Pap II smears. Med Arch, 2005; 59(1): 47-51.
4. Petignat P, Faltin D, Goffin F et al: Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinoma. Cancer, 2005; 105(3): 126-32.
5. Tjalma WA, Van Waes TR, Van den Eeden LE et al: Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Pract Res Clin Obstet Gynaecol, 2005; 19: 469-83.
6. Winer RL, Hughes JP, Feng Q et al: Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomarkers Prev, 2011; 20(4): 699-707.
7. Moscicki AB, Ma Y, Wibbelsman C et al: Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol, 2010; 116(6): 1373-80.
8. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2002; 2(5): 342-50.
9. de Sanjosé S, Diaz M, Castellsagué X et al: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 2007; 7(7): 453-59.
10. Palefsky JM, Holly EA: Chapter 6: Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr, 2003; (31): 41-46.
11. Palefsky J: Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS, 2009; 4(1): 52-56.
12. Heard I, Schmitz V, Costagliola D et al: Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS, 1998; 12(12): 1459-64.
13. Courtney AE, Leonard N, O'Neill CJ et al: The uptake of cervical cancer screening by renal transplant recipients. Nephrol Dial Transplant, 2009; 24(2): 647-52.
14. Brown MR, Noffsinger A, First MR et al: HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol, 2000; 79(2): 220-24.
15. Seshadri L, George SS, Vasudevan B et al: Cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant recipients. Indian J Cancer, 2001; 38(2-4): 92-95.
16. Morrison EA, Dole P, Sun XW et al: Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients. Nephrol Dial Transplant, 1996; 11(8): 1603-6.
17. Bardin A, Vaccarella S, Clifford GM et al: Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer, 2008; 44(4): 557-64.
18. Nowak Z, Karowicz-Bilińska A: Human papilloma virus infection in pregnant women with normal pap-smears, HPV oncogenity and risk factors. Ginekol Pol, 2007; 78(9): 678-84.
19. Tarka A, Szczepańska M, Rokita W et al: Risk assessmant of chronic HPV HR infection in babies who contacted the virus in the perinatal period. Ginekol Pol, 2011; 82(9): 664-69.
20. Paternoster DM, Cester M, Resente C et al: Human papilloma virus infection and cervical intraepithelial neoplasia in transplanted patients. Transplant Proc, 2008; 40(6): 1877-80.
21. Origoni M, Stefani C, Dell'Antonio G et al: Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow- up study. J Clin Virol, 2011; 51(4): 250-54.
22. Meeuwis KA, van Rossum MM, van de Kerkhof PC et al: Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients. Transpl Int, 2010; 23(2): 191-99.
23. Watorek E, Boratynska M, Smolska D et al: Malignancy after renal transplantation in the new era of immunosuppression. Ann Transplant, 2011; 16(2): 14-18.
24. Ekiel AM, Friedek DA, Romanik MK et al: Occurrence of Ureaplasma parvum and Ureaplasma urealyticum in women with cervical dysplasia in Katowice, Poland. J Korean Med Sci, 2009; 24(6): 1177-81.
25. Wallin KL, Wiklund F, Luostarinen T et al: A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer, 2002; 101(4): 371-74.
26. Lukic A, Canzio C, Patella A et al: Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum. Anticancer Res, 2006; 26(6C): 4843-49